Floatz logo

Enalapril Maleate

Childhood Neoplasm

Children's Oncology GroupUNKNOWNPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Childhood Neoplasm cohort.

Asset / SponsorPhaseRating
Etoposide
City of Hope Medical Center
Phase 2/3BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2/3BBB
Nivestim
Barbara Ann Karmanos Cancer Institute
Phase 3BBB
Carboplatin
Seoul National University Hospital
Phase 2/3BBB
Irinotecan
EpicentRx, Inc.
Phase 2BBB

View all 50 →

Same molecule, other indications

Enalapril Maleate is also rated in:

hyperhomocysteinemiaDormant
BB
Indicative · Phase 4
69 / 100
View asset →
essential hypertensionDormant
BB
Indicative · Phase 4
67 / 100
View asset →
hypertensive disorderDormant
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →